Clinical Trial Update: Influence of Pioglitazone for Renal Transplant Function in Diabetics [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pioglitazone for maintaining renal transplant function in diabetics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Kidney Transplantation
• Proteinuria

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Diabetes Mellitus, Kidney Transplantation | Phase 3 | Status: COMPLETED